Annotation Detail for ARPP21
Basic Information
Top
Desease Name |
---|
NEUROLOGICAL |
Cognitive performance |
Desease Name |
---|
Cognitive performance |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D019259 |
Lamivudine |
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of ARPP21 mRNA | affects cotreatment|increases expression | 16931933
|
D019259 |
Lamivudine |
[Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of ARPP21 mRNA | affects cotreatment|increases expression | 16931933
|
D019259 |
Lamivudine |
[Zidovudine co-treated with Lamivudine] results in increased expression of ARPP21 mRNA | affects cotreatment|increases expression | 16931933
|
D019469 |
Indinavir |
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of ARPP21 mRNA | affects cotreatment|increases expression | 16931933
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ARPP21 mRNA | affects binding|increases activity|increases expression | 19710929
|
D019258 |
Saquinavir |
[Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of ARPP21 mRNA | affects cotreatment|increases expression | 16931933
|
D015215 |
Zidovudine |
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of ARPP21 mRNA | affects cotreatment|increases expression | 16931933
|
D015215 |
Zidovudine |
[Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of ARPP21 mRNA | affects cotreatment|increases expression | 16931933
|
D015215 |
Zidovudine |
[Zidovudine co-treated with Lamivudine] results in increased expression of ARPP21 mRNA | affects cotreatment|increases expression | 16931933
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000163 |
Acquired Immunodeficiency Syndrome |
|
Zidovudine |
5.31 | 9612607 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.52 | 18653653 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
4.02 | 16434500 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
3.52 | 19483382 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
3.08 | 19176532 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.56 | 18249437 |
MESH:D004362 |
Drug Toxicity |
|
Lamivudine |
9.67 | 15040536 |
MESH:D004362 |
Drug Toxicity |
|
Zidovudine |
9.67 | 15040536 |
MESH:D004487 |
Edema |
|
pirinixic acid |
2.85 | 12083418 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
9.21 | 19236843 20131406 |
MESH:D005234 |
Fatty Liver |
|
Zidovudine |
9.21 | 18299183 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.73 | 20558911 |
MESH:D006402 |
Hematologic Diseases |
|
Zidovudine |
5.12 | 12579204 |
MESH:D006509 |
Hepatitis B |
|
Lamivudine |
5.47 | 17703166 |
MESH:D019694 |
Hepatitis B, Chronic |
|
Lamivudine |
5.47 | 15309715 15631357 16476009 12044531 15274664 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
3.48 | 19176532 18467677 19772884 16221962 |
MESH:D015658 |
HIV Infections |
|
Indinavir |
16.88 | 15388451 11363243 11141242 |
MESH:D015658 |
HIV Infections |
|
Lamivudine |
16.88 | 11141242 20032539 17530837 9296927 |
MESH:D015658 |
HIV Infections |
|
Saquinavir |
16.88 | 15388451 11141242 |
MESH:D015658 |
HIV Infections |
|
Zidovudine |
16.88 | 11363243 20032539 11141242 11698656 17358032 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.53 | 20558911 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.85 | 16306350 |
MESH:D007680 |
Kidney Neoplasms |
|
Zidovudine |
4.09 | 12579204 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
Zidovudine |
4.79 | 20370541 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
1.35 | 15474484 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
1.92 | 20007298 15890375 16377806 |
MESH:D008175 |
Lung Neoplasms |
|
Zidovudine |
2.49 | 18800350 |
MESH:D048629 |
Micronuclei, Chromosome-Defective |
|
Zidovudine |
6.45 | 17358032 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.99 | 16239165 |
MESH:D009164 |
Mycobacterium Infections |
|
Indinavir |
6.02 | 21442799 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.26 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.22 | 16411023 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
2.09 | 17405874 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.88 | 20558911 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.53 | 19058328 |
MESH:D012206 |
Rhabdomyolysis |
|
Lamivudine |
6.08 | 9296927 |
MESH:D013274 |
Stomach Neoplasms |
|
Zidovudine |
2.48 | 17696246 |
MESH:D014625 |
Vaginal Neoplasms |
|
Zidovudine |
5.24 | 12579204 |